8th Joint ECDC/WHO Europe Annual European Influenza and COVID-19 Surveillance Meeting

Expert meeting
5 Feb 2022 - 7 Feb 2022

From 5th to 7th October 2022, the 8th Joint European Centre for Disease Prevention and Control (ECDC) and WHO Regional Office for Europe (WHO/Europe) Influenza and COVID-19 Surveillance Meeting was held online. This was the second annual meeting to be held online and included reflections on the COVID-19 pandemic.


Alina Druc: Monitoring virus activity

Ana Paula Rodrigues: SARS-CoV-2 seroprevalence studies: the Portuguese experience in last 2 years and next steps

Catherine Pendrey: Influenza Season, Australia 2022

Bernd Manfred Gawlik: Wastewater based surveillance in the EU

Lisa Domegan: Data use for severity and risk assessment experience from Ireland

Matthew Biggerstaff: Connecting Forecasting Research to Decision making Needs: Lessons Learned from CDC organized Activities

Hassan Hartman: Genome-based surveillance of resistance to COVID-19 therapeutics in the UK

Giuseppina La Rosa, Elisabetta Suffredini, Luca Lucentini: Developments in SARS-CoV-2 wastewater surveillance in Italy

Ron A.M. Fouchier: Influenza virus surveillance strategy in the Netherlands

Ron A.M. Fouchier: Support to microbiology-related activity

Itay Bar Or: Israel wastewater surveillance for respiratory viruses

Harriet Ware: SeroTracker: An updated snapshot of serosurveys and seroprevalence trends in the
EURO region

Irina Eero/Olga Sadikova: Data linkage and flow Influenza SARS CoV 2

Nicola S. Lewis: Influenza virus characteristics and update from the September 2022 Vaccine Composition Meeting

Nathalie Bossuyt: Implementing Integrated Surveillance of Respiratory Viruses in Belgium

Mark Katz: The European SARI Vaccine Effectiveness Network (Euro SAVE): Enhancing existing SARI platforms to estimate Covid and influenza VE

Esther Kissling: Vaccine effectiveness against influenza A(H1N1)pdm09 and A(H3N2): I MOVE primary care multicentre study, Europe, 2021 22

Ralf Dürrwald: Molecular surveillance of pandemic SARS CoV 2 in Germany: Sampling approach and specimen logistical issues affecting downstream virus characterization)

R. Daja: Evaluation of COVID-19 and influenza Vaccine Effectiveness among Healthcare Workers in

Paola Stefanelli: SARS-CoV-2 Genomic surveillance activities in Italy

Odette Popovici: The integrated surveillance for respiratory viruses (and other etiologies) in the SARI sentinel, Romania, season 2022 2023

Olav Hungnes: Experiences from national registry based virological surveillance, Norway

Nicole Wolter: Update on Influenza and SARS-CoV-2 in South Africa

Oluwatosin Akande: Genomic surveillance strategy

Silvia Bino: Data reports through an Integrated Digitalized Sentinel ILI/SARI Surveillance in Albania

R. Kalda, M. Jürisson, L. Dotsenko: Country wide seroepidemiological study on the spread of SARS CoV 2. Estonian experience

Silke Bude: Integrated Respiratory Illness Surveillance in Germany

Sabrina Bacci: ECDC Vaccine Effectiveness, Burden and Impact Studies (VEBIS) for COVID 19 and Influenza

R. Niehus: Session 7: Use of modelling in the next season

Raquel Guiomar: Portugal - on the experience for SARS-CoV-2 and influenza